A review of maternally inherited diabetes and deafness

Frontiers in Bioscience - Landmark

Volumn 19, Issue 5, 2014, Pages 777-782

  Li, Hui Zhen ^a   Li, Rui Yu ^a   Li, Meng ^b  

^a Xingtai Medical College   (China)

^b Health Team of Hotan Prefecture Detachment of Chinese Armed Police Force   (China)

Author keywords

ACE I; MIDD; mtTFA; NIDDM; Review; RFLP

Indexed keywords

MITOCHONDRIAL DNA;

FEMALE; GENETICS; HEARING IMPAIRMENT; HUMAN; MOLECULAR DIAGNOSIS; MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREGNANCY; REVIEW;

DEAFNESS; DIABETES MELLITUS, TYPE 2; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; PREGNANCY;

EID: 84904280569     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4244     Document Type: Review

References (37)

1. Salvatore DiMauro& Guido Davidzon (2005). Mitochondrial DNA and disease" Department of Neurology, Columbia University Medical Center. Retrieved March 20, 2013.
2. van den Ouweland JM, Lemkes HH, Ruitenbeek W. Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1(5),368-71. (1992)
3. Maassen JA, Janssen GM, t Hart LM. Molecular mechanisms of mitochondrial diabetes (MIDD). Ann Med 37 (3),213-21. (2005)
4. Goto Y-I, Nonaka I, Horai S. A mutation in the tRNALeu(UUR)gene associated with the MELAS subgroup of mitochondrialencephalomyopathies. Nature 348, 651-653. (1990)
5. Guillausseau PJ, Massin P, Dubois-Laforge D, Timsit J, Virally M,Gin H. Maternally inherited diabetes and deafness: a multicenterstudy. Ann Intern Med 134, 721-728. (2001)
6. Majamaa-Voltti K, Peuhkurinen KJ, Kortelainen M, Hassinen IE,Majamaa K. Cardiac abnormalities in patients with mitochondrialDNA mutation 3243A>G. BMC Cardiovascular Disorders 2, 12. (2002)
7. Yamagata K, Muro K, Usui J, Hagiwara M, Kai H, Arakawa Y Mitochondrial DNA mutations in focal segmental glomerulosclerosislesions. J Am SocNephrol 13, 1816-1823. (2002)
8. Guillausseau PJ, Dubois-Laforge D, Massin P, Laloi-Michelin M,Bellanne-Chantelot C, Gin H Heterogeneity of diabetesphenotype in patients with 3243-bp mutation of mitochondrialDNA (maternally inherited diabetes and deafness or MIDD). Diabetes Metab 30, 181-186. (2004)
9. Aoki Y, Hosaka S, Kiyosawa K. Intestinal pseudoobstruction in adiabetic man: role of the mitochondrial A3243G mutation. Ann Intern Med 137, 703-704. (2002)
10. Schuit F, Flamez D, De Vos A, Pipeleers D. Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes 51(Suppl 3),S326-32. (2002)
11. Hayakawa T, Noda M, Yasuda K, Yorifuja H, Taniguchi S,Miva I. Ethidium bromide-induced inhibitionof mitochondrial gene transcription suppresses glucose-stimulated insulin release in the mouse pancreatic beta-cellline betaHC9. J Biol Chem 273,20300-7. (1998)
12. Silva JP, Kohler M, Graff C, Oldfors A, Magnuson MA,Berggren PO. Impaired insulin secretion and beta-cellloss in tissue-specific knockout mice with mitochondrialdiabetes. Nat Genet 26,336-40. (2000)
13. P.B.M. de Andrade, B. Rubi, F. Frigerio, J.M.W. van den Ouweland, J.A. Massen, P. Maechler. Diabetes-associated mitochondrial DNA mutation A3243G impairs cellular metabolic pathways necessary for beta cell function. Diabetologia 49,1816-1826. 2006 () (Pubitemid 44025036)
14. Philippe Ravassard, YasmineHazhouz, SeverinePechberty, Emilie Bricout-Neveu, Mathieu Armanet, Paul Czernichow and Raphael Scharfmann. A genetically engineered human pancreatic □ cell line exhibiting glucose-inducible insulin secretion. J Clin Invest 121(9),3589-3597. (2011)
15. Mezghani N, Mnif M, Mkaouar-Rebai E, Kallel N, Charfi N, Abid M, Fakhfakh F. A maternally inherited diabetes and deafness patient with the 12S rRNA m. 1555A>G and the ND1 m.3308T>C mutations associated with multiple mitochondrial deletions. Biochem Biophys Res Commun 431(4),670-674. (2013)
16. Janssen GM, Neu A, t Hart LM, van de Sande CM, AntonieMaassen J. Novel mitochondrial DNA length variants and genetic instability in a family with diabetes and deafness. Exp ClinEndocrinol Diabetes 114(4),168-74. (2006)
17. R. Murphy, D.M. Turnbull, M. Walker, A.T. Hattersley. Clinical features, diagnosis and management of maternally inherited diabetes and deafness (MIDD) associated with the 3243A>G mitochondrial point mutation. Diabet Med 25(4),383-99. (2008)
18. Nesbitt V, Pitceathly RD, Turnbull DM. The UK MRC mitochondrial disease patient cohort study: clinical phenotypes associated with the m. 3243A>G mutation-implications for diagnosis and management. J NeurolNeurosurg Psychiatry 84(8),936-938. (2013)
19. Matthews PM, Hopkin J, Brown RW, Stephenson JB, Hilton-Jones D, Brown GK. Comparison of the relative levels of the 3243 (A→G) mtDNA mutation in heteroplasmic adult and fetal tissues. J Med Genet 31(1),41-44. (1994)
20. Cardaioli E, Fabrizi GM, Grieco GS, Dotti MT, Federico A. Heteroplasmy of the A3243G transition of mitochondrial tRNA(Leu(UUR)) in a MELAS case and in a 25-week-old miscarried fetus. J Neurol 247(11),885-887. (2000)
21. Jenuth JP, Peterson AC, Shoubridge EA. Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice. Nat Genet 16(1),93-95. (1997)
22. Jokinen R, Marttinen P, Sandell HK. Gimap3 regulates tissue-specific mitochondrial DNA segregation. Plos Genet 6(10),e1001161. (2010)
23. Jokinen R, Battersby BJ. Insight into mammalian mitochondrial DNA segregation.Ann Med 45(2),149-155. (2013)
24. Asano T, Tsukuda K, Katagiri H. Clinical relevance of heterplasmic concentration of mitochondrial A3242G mutation in leucocytes. Diabetologia 42(12),1439-1440. (1999)
25. van Essen EH, Roep BO, t Hart LM. HLA-DQ polymorphism and degree of heteroplasmy of the A3243G mitochondrial DNA mutation in maternally inherited diabetes and deafness. Diabet Med 17(12),841-847. (2000)
26. Laloi-Michelin M, Meas T, Ambonville C. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J ClinEndocrinolMetab 94(8),3025-30. (2009)
27. de Laat P, Koene S, van den Heuvel LP. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m. 3243A>G mutation. J Inherit Metab Dis 35(6),1059-1069. (2012)
28. Sue CM, Quigley A, Katasbanis S. Detection of MELAS A3243G point mutation in muscle, blood and hair follicles. J Neuro Sci 161(1),36-39. (1998)
29. Procaccio V, Neckelmann N, Paquis-Flucklinger V. Detection of low levels of the mitochondrial tRNALeu(UUR) 3243A>G mutation in blood derived from patients with diabetes. MolDiagnTher 10(6),381-389. (2006)
30. Singh R, Ellard S, Hattersley A, Harries LW. Rapid and sensitive real-time polymerase chain reaction method for detection and quantification of 3243A>G mitochondrial point mutation. J MolDiagn 8(2), 225-230. (2006)
31. Urata M, Wakiyama M, Iwase M. New sensitive method for the dection of the A3243G mutation of human mitochondrial deoxyribonucleic acid in diabetes mellitus patients by ligation-mediated polymerase chain reaction.Clin Chem 44(10),2088-2093. (1998)
32. Maassen JA, T Hart LM, Van Essen E. Mitochondrial diabetes, molecular mechanisms and clinical presentation. Diabetes 53(Suppl 1),S103-109. (2004)
33. Guery B, Choukroun G, Noel LH. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am SocNephrol 14(8),2099-2108. (2003)
34. Silveiro SP, Canani LH, Maia AL. Myocardial dysfunction in maternally inherited diabetes and deafness. Diabetes Care 26(4),1323-1324. (2003)
35. Sinnathuray AR, Raut V, Awa A. A review of cochlear implantation in mitochondrial sensorineural hearing loss.OtolNeurotol 24(3),418-426. (2003)
36. Damian MS, Hertel A, Seibel P. Follow-up in carriers of the 'MELAS' mutation without strokes. Eur Neurol 39(1),9-15. (1998)
37. Folmes CD, Martinez-Fernandez A, Perales-Clemente E. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS. Stem Cells 31(7),1298-1308. (2013)